Clareon PanOptix by Alcon

Alcon’s Clareon PanOptix is the global leader in trifocal intraocular lenses (IOLs), and with more than 2.2 million implants worldwide,¹ there are plenty of reasons for its success. Clareon PanOptix offers a leading presbyopia correcting IOL for cataract patients seeking a full range of vision after surgery. Nine out of 10 Clareon PanOptix patients did not require spectacles at any distance following surgery.²

A low glistening IOL with a smooth optic, Clareon PanOptix delivers among the lowest levels of surface haze, providing patients with clarity and stability.*^3-7 Patients can achieve exceptional vision at every meaningful distance.

PanOptix is the world’s favourite trifocal IOL, with a patient satisfaction rate of 99.2%.^8-11 Additionally, 98.4% of Clareon PanOptix patients would recommend the lens to a friend.**¹²

Contact: Alcon Account Manager

*Glistening free is defined as Miyata grade 0 or 25mv/mm2. **Response to the following question on IOLSAT questionnaire at six-months post-op: “Given your vision today, would you recommend the lenses you had implanted to your family or friends?” Based on data for AcrySocf IQ PanOptix Trifocal IOL.

References

1. Alcon data on file, 2022.
2. ZHU – Rate of complete spectacle independence with a trifocal intraocular lens (v1.0) – 91.6% of PanOptix patients reported never requiring spectacles for any distance (p.1) Nineteen unique clinical studies were identified. Based on a meta-analysis of 13 studies (N = 513 patients), the complete spectacle independence.
3. Alcon data on file. TDOC-0057291.
4. Stanojcic N., OʼBrart D., Hull C., et al., Visual and refractive outcomes and glistenings occurrence after implantation of two hydrophobic acrylic aspheric monofocal IOLs. J Cataract Refract Surg. 2020;46(7):986-99.
5. Oshika T., Fujita Y., Inamura M., Miyata K., Mid-term and long-term clinical assessments of a new one-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687. DOI:10.1097/j.crs.0000000000000142.
6. Maxwell A., Suryakumar R., Long-term effectiveness, and safety of a three-piece acrylic hydrophobic intraocular lens modified with hydroxyethyl-methacrylate: an open-label, three-year follow-up study. Clin Ophthalmol. 2018;12:2031-2037. Published 2018 Oct 11. DOI:10.2147/OPTH.S175060.
7. Society Annual Meeting. 2008;52(19):1614-1617. DOI.10.1177/154193120805201965.
8. Böhm M., Petermann K., Hemkeppler E., Kohnen T., Defocus curves of four presbyopia-correcting IOL designs: Diffractive panfocal, diffractive trifocal, segmental refractive, and extended depth of focus. J Cataract Refract Surg. 2019;45(11):1625-1636. Doi:10.1016/j.jcrs.2019.07.014.
9. Kohnen T., Herzog M., Hemkeppler E., et al., Visual performance of a quadrifocal (trifocal) intraocular lens following removal of the crystalline lens. AM J Ophthalmol. 2017;184:52-62. DOIi:10.1016/j. ajo.2017.09.0916.
10. Clareon PanOptix, Directions for use, 08/2021; www.ifu.alcon.com.
11. Modi et al., Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. 2020 Sep 28;S0161-6420(20)30677-1.
12. Clareon PanOptix Claims Matrix – Global-IMG (v1.0)